Home / Cancer and immune system / Neratinib
ATC L01EH02 · Human Epidermal Growth Factor Receptor 2 (HER2) Tyrosine Kinase Inhibitors
Neratinib shortage
As of 2 Nov 2026, Neratinib has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Countries1/16
Products1packs or presentations
Companies10 listed
Short since14 Jul 20264 months ago
Earliest returnnot givencompany estimate
Main reasonDistribution or logistics
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
Canada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group L01EH · Human Epidermal Growth Factor Receptor 2 (HER2) Tyrosine Kinase InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | NERLYNX (180 tablets) | KNIGHT THERAPEUTICS INC. | 14 Jul 2026 | not given | Distribution or logistics Delay in shipping of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.